Levodopa Dose-Related Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone: Findings from EPSILON Study

Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL

https://onlinelibrary.wiley.com/doi/10.1111/ene.70629

J. Ferreira 1; O. Rascol 2; F. Stocchi 3; A. Antonini 4; H. Brigas 5; J. Moreira 5; J. Rocha 5; M. Fonseca 6; D. Ramos 5; J. Holenz 5; W. Poewe 7

Jun 12, 2026